HNRNPA1 and gastric cancer: In addition, Ba yi combined in vitro and in vivo experiments and found that GC cells derived exo-lncFERO controls GCSC tumorigenic properties through suppressing ferroptosis, and targeting exo-lncFERO/hnRNPA1/SCD1 axis combined with chemotherapy could be a promising CSC-based strategy for the treatment of GC (22).